Literature DB >> 12207984

Progressive impairment of constructional abilities: a visuospatial sketchpad deficit?

Costanza Papagno1.   

Abstract

The case of a patient, PC, with an impairment of constructional abilities due to a progressive degenerative disease is described. Ideomotor apraxia was also present. PC showed difficulties in all tasks requiring a "manipulation" of a visual model or requiring a visual model to address a specific movement or a choice among alternatives. The spatial component of mental imagery was also severely impaired. The conclusion was that the patient presented a deficit of the rehearsal component of the visuospatial sketchpad (VSSP). This produced an impairment of spatial learning, but spatial retrograde memory was preserved, as well as object recognition. The most prominent sites of atrophy were located in the parietal lobe bilaterally. A 3-year follow-up is reported, showing a progressive impairment of verbal abilities.

Entities:  

Mesh:

Year:  2002        PMID: 12207984     DOI: 10.1016/s0028-3932(02)00072-6

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  4 in total

1.  Changes in artistic style after minor posterior stroke.

Authors:  J M Annoni; G Devuyst; A Carota; L Bruggimann; J Bogousslavsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

2.  Italian normative data for the Battery for Visuospatial Abilities (TERADIC).

Authors:  Luigi Trojano; Mattia Siciliano; Roberto Pedone; Chiara Cristinzio; Dario Grossi
Journal:  Neurol Sci       Date:  2015-02-19       Impact factor: 3.307

3.  The factorial structure of the Mini-Mental State Examination (MMSE) in Japanese dementia patients.

Authors:  Kenta Shigemori; Shohei Ohgi; Eriko Okuyama; Takaki Shimura; Eric Schneider
Journal:  BMC Geriatr       Date:  2010-06-09       Impact factor: 3.921

4.  Medial-Vowel Writing Difficulty in Korean Syllabic Writing: A Characteristic Sign of Alzheimer's Disease.

Authors:  Ji Hye Yoon; Yong Jeong; Duk L Na
Journal:  J Clin Neurol       Date:  2018-02-28       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.